Bill
Bill > HB4721
WV HB4721
WV HB4721Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
summary
Introduced
01/22/2026
01/22/2026
In Committee
01/22/2026
01/22/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
The purpose of this bill is to add a provision in Schedule I drugs relating to the scheduling of crystalline polymorph psilocybin, if approved by the Food and Drug Administration and the Drug Enforcement Administration, and declare that will be lawful to prescribe, distribute and market this drug.
AI Summary
This bill proposes to amend West Virginia's controlled substances act by adding a new provision to Schedule I, which lists drugs with a high potential for abuse and no currently accepted medical use. Specifically, it states that if a crystalline polymorph psilocybin substance, such as COMP360, is approved by the U.S. Food and Drug Administration (FDA) and scheduled by the Drug Enforcement Administration (DEA), it will be lawful to prescribe, distribute, and market this drug. This change would allow for the legal use of this specific form of psilocybin for medical purposes, provided it meets the rigorous approval processes of federal agencies.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
To House Health and Human Resources (on 01/22/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | http://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=4721&year=2026&sessiontype=RS&btype=bill |
| BillText | http://www.wvlegislature.gov/Bill_Status/bills_text.cfm?billdoc=hb4721%20intr.htm&yr=2026&sesstype=RS&i=4721 |
Loading...